A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C

Clinical trial NCT07590167 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07590167
Sponsor: Addpharma Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Dyslipidemia Hypertension

Start date: 2026-06-01
Primary completion: 2026-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.